Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 23, 2023 09:00 ET | Source: InSilico Medicine

Insilico Medicine Announces IND Approval of Oral 3CLpro Inhibitor ISM3312 for COVID-19

New York, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ISM3312 is a highly selective 3CLpro inhibitor with a novel molecular structure optimized from compounds designed by Chemistry42, Insilico’s...
February 01, 2023 09:27 ET | Source: InSilico Medicine

Insilico Medicine Opens Largest AI-Powered Biotechnology Research Center in the Middle East

Abu Dhabi, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine ("Insilico"), a clinical-stage artificial intelligence (AI)-driven drug discovery company, is announcing today the opening of the...
November 29, 2022 09:00 ET | Source: InSilico Medicine

Insilico Medicine to Present at 41st Annual J.P. Morgan Healthcare Meeting

New York, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine will present at the 41st Annual J.P. Morgan Healthcare Meeting happening Jan. 9-12, 2023 at the Westin St. Francis Hotel in San...
November 08, 2022 09:00 ET | Source: InSilico Medicine

Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion

Abu Dhabi, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug discovery company, announced a multi-year, multi-target strategic research...
November 08, 2022 09:00 ET | Source: InSilico Medicine

Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion

New York, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug discovery company, announced a multi-year, multi-target strategic research...